A smarter way to curb drug prices through imports
By Henry I. Miller, M.S., M.D. and John J. Cohrssen
The Trump administration last week announced steps that could lead to the importation of prescription drugs from Canada, where prices are lower. It is a goal supported by President Trump, but long opposed by many Republicans . . .
Instead of pushing for piecemeal steps that will continually run into political opposition and legal challenges, the administration should take a broader approach — by establishing reciprocity of drug approvals by foreign regulatory agencies whose regulatory evaluations are comparable to the FDA’s . . .